OPKO Health Reports Q3 Non-GAAP EPS of -$0.07, Missing Estimates
OPKO Health (NASDAQ: OPK) reported third-quarter financial results featuring a non-GAAP earnings per share (EPS) of -$0.07, which missed analyst expectations by $0.01. The company recorded total revenue of $65.4 million for the period. The report comes amidst strategic developments involving the company's BioReference Health division, with Labcorp indicating interest in acquiring select assets from the unit for a potential value of up to $872 million. This asset sale could significantly impact OPKO's capital structure and long-term strategic direction.
Topics: asset sale earnings miss revenue report